Breaking News Instant updates and real-time market news.

MYL

Mylan

$35.94

-0.9 (-2.44%)

07:29
10/10/16
10/10
07:29
10/10/16
07:29

Mylan settlement, updated guidance a positive, says JPMorgan

JPMorgan analyst Chris Schott views Mylan's $465M settlement with the Department of Justice relating to the potential misclassification of Epipen in the Medicaid Drug Rebate Program as well as its updated 2016 guidance as a positive. The news "removes litigation overhang at a reasonable cost and highlights the diversification of the base business and inexpensive valuation," Schott tells investors in a research note. He keeps an Overweight rating on Mylan with a $52 price target.

  • 09

    Nov

  • 28

    Mar

MYL Mylan
$35.94

-0.9 (-2.44%)

10/04/16
JPMS
10/04/16
NO CHANGE
Target $52
JPMS
Overweight
Mylan price target lowered to $52 from $62 at JPMorgan
JPMorgan analyst Chris Schott lowered his price target for Mylan to $52 saying he remains cautious on the shares over the near-term given the ongoing Epipen controversy. The analyst, however, views the stock as "very inexpensive" and keeps an Overweight rating on the name. Schott sees a limited long-term impact to his thesis from the Epipen controversy and believes Mylan's generics business is underappreciated. He maintains an Overweight rating on the shares.
10/10/16
RAJA
10/10/16
UPGRADE
RAJA
Strong Buy
Mylan upgraded to Strong Buy from Market Perform at Raymond James
10/10/16
UBSW
10/10/16
NO CHANGE
Target $60
UBSW
Buy
UBS remains constructive on Mylan despite governance controversy
UBS analyst Marc Goodman said he remains constructive on Mylan despite the controversy surrounding its corporate governance. Goodman cited the company's ability to execute, its surprise announcement of a EpiPen Medicaid lawsuit settlement and its updated guidance, which was better than feared. Goodman reiterated his Buy rating and lowered his price target to $60 from $66 on Mylan shares.
10/10/16
RAJA
10/10/16
UPGRADE
Target $57
RAJA
Strong Buy
Mylan upgraded to Strong Buy on EpiPen settlement at Raymond James
As previously reported, Raymond James upgraded Mylan two notches to Strong Buy from Market Perform and established a $57 price target. Analyst Elliot WIlbur said the Department of Justice settlement over EpiPen rebates eliminates a significant overhang on shares enabling the focus to be back on fundamentals. With depressed absolute and relative valuation levels, Wilber sees favorable risk/reward scenarios even in a more tempered earnings growth environment.

TODAY'S FREE FLY STORIES

09:45
02/28/17
02/28
09:45
02/28/17
09:45
General news
U.S. equities are flatlining ahead of Trump's SOTU speech »

U.S. equities are…

09:45
02/28/17
02/28
09:45
02/28/17
09:45
General news
Consumer Confidence to be reported at 10:00 »

February Consumer…

HPP

Hudson Pacific

09:43
02/28/17
02/28
09:43
02/28/17
09:43
Downgrade
Hudson Pacific rating change  »

Hudson Pacific downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

CMCSA

Comcast

$37.53

-0.36 (-0.95%)

, CMCSK

Comcast

09:41
02/28/17
02/28
09:41
02/28/17
09:41
Hot Stocks
Comcast NBCUniversal to acquire remaining 49% stake in Universal Studios Japan »

Comcast NBCUniversal…

CMCSA

Comcast

$37.53

-0.36 (-0.95%)

CMCSK

Comcast

GS

Goldman Sachs

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

  • 03

    Mar

  • 06

    Mar

AMTD

TD Ameritrade

$43.66

0.25 (0.58%)

, P

Pandora

09:41
02/28/17
02/28
09:41
02/28/17
09:41
Options
Unusually active option classes on open February 28th »

Unusual total active…

AMTD

TD Ameritrade

$43.66

0.25 (0.58%)

P

Pandora

HTZ

Hertz

NEM

Newmont Mining

VRX

Valeant

WMT

Wal-Mart

X

U.S. Steel

T

AT&T

CRM

Salesforce

GLD

SPDR Gold Trust

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 02

    Mar

  • 06

    Mar

  • 06

    Mar

  • 14

    Mar

  • 14

    Mar

  • 14

    Mar

  • 19

    Mar

SIG

Signet Jewelers

09:39
02/28/17
02/28
09:39
02/28/17
09:39
Technical Analysis
Signet Jewelers drops to new 52-week low in early trading »

The stock is down over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Mar

MTU

Mitsubishi UFJ

09:38
02/28/17
02/28
09:38
02/28/17
09:38
Upgrade
Mitsubishi UFJ rating change  »

Mitsubishi UFJ upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZR

Caesars

$9.45

0.3 (3.28%)

, LVS

Las Vegas Sands

09:38
02/28/17
02/28
09:38
02/28/17
09:38
Hot Stocks
Nevada reports January Statewide gaming win up 12.02% to $1.04B »

Reports December Las…

CZR

Caesars

$9.45

0.3 (3.28%)

LVS

Las Vegas Sands

WYNN

Wynn Resorts

$95.51

1.5 (1.60%)

PENN

Penn National

$14.47

0.25 (1.76%)

MGM

MGM Resorts

BYD

Boyd Gaming

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

DF

Dean Foods

09:36
02/28/17
02/28
09:36
02/28/17
09:36
Upgrade
Dean Foods rating change  »

Dean Foods upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

09:34
02/28/17
02/28
09:34
02/28/17
09:34
Hot Stocks
Target sees 2%-4% sales lift from reimagined stores »

Says to open 30 new small…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 19

    Mar

JPM

JPMorgan

09:33
02/28/17
02/28
09:33
02/28/17
09:33
Hot Stocks
Breaking Hot Stocks news story on JPMorgan »

JPMorgan says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 03

    Mar

  • 14

    Jul

  • 12

    Oct

  • 13

    Apr

  • 13

    Jul

  • 12

    Oct

09:33
02/28/17
02/28
09:33
02/28/17
09:33
General news
Market opens with modest losses »

Stock futures drifted…

JBT

JBT Corporation

09:32
02/28/17
02/28
09:32
02/28/17
09:32
Upgrade
JBT Corporation rating change  »

JBT Corporation upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

BCOV

Brightcove

$8.20

0.05 (0.61%)

, HUBS

HubSpot

09:31
02/28/17
02/28
09:31
02/28/17
09:31
Hot Stocks
Brightcove, HubSpot announce partnership »

Brightcove (BCOV) and…

BCOV

Brightcove

$8.20

0.05 (0.61%)

HUBS

HubSpot

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 02

    Mar

  • 13

    Mar

  • 14

    Mar

ESND

Essendant

$22.09

0.34 (1.56%)

09:31
02/28/17
02/28
09:31
02/28/17
09:31
Downgrade
Essendant rating change  »

Essendant downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

HYH

Halyard Health

09:30
02/28/17
02/28
09:30
02/28/17
09:30
Downgrade
Halyard Health rating change  »

Halyard Health downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:30
02/28/17
02/28
09:30
02/28/17
09:30
General news
The U.S. advance indicators report »

The U.S. advance…

09:30
02/28/17
02/28
09:30
02/28/17
09:30
General news
Chicago PMI Business Barometer Index to be reported at 09:45 »

February Chicago PMI…

PFE

Pfizer

09:29
02/28/17
02/28
09:29
02/28/17
09:29
Hot Stocks
FDA sends Pfizer's Hospira warning letter over manufacturing »

The FDA sent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

  • 09

    Mar

  • 17

    Mar

  • 23

    Mar

  • 01

    Apr

  • 27

    Aug

FRO

Frontline

09:28
02/28/17
02/28
09:28
02/28/17
09:28
Hot Stocks
Breaking Hot Stocks news story on Frontline »

Frontline raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

VZ

Verizon

, BPL

Buckeye Partners

09:28
02/28/17
02/28
09:28
02/28/17
09:28
Conference/Events
Morgan Stanley to hold a conference »

MLP/Diversified Natural…

VZ

Verizon

BPL

Buckeye Partners

CEQP

Crestwood Equity

ENLC

EnLink Midstream

ENLK

EnLink Midstream Partners

EPD

Enterprise Products

SEMG

SemGroup

VLP

Valero Energy Partners

OGS

ONE Gas

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 02

    Mar

  • 06

    Mar

SCHW

Charles Schwab

09:27
02/28/17
02/28
09:27
02/28/17
09:27
Hot Stocks
Charles Schwab lowers standard online equity and ETF trade commissions »

The Charles Schwab…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FRO

Frontline

09:25
02/28/17
02/28
09:25
02/28/17
09:25
Earnings
Frontline reports Q4 adj. EPS 22c, consensus 12c »

Reports Q4 revenue $128M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

EFX

Equifax

09:25
02/28/17
02/28
09:25
02/28/17
09:25
Conference/Events
Equifax to hold a webcast »

Equifax Senior Vice…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 01

    Mar

  • 02

    Mar

  • 02

    Mar

LGND

Ligand

$107.38

7 (6.97%)

09:25
02/28/17
02/28
09:25
02/28/17
09:25
Conference/Events
Ligand to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 02

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.